Latest! Astrazeneca PR News: 3,279+ Press Releases in Global

Retail Pr News

Neuropsychiatric Disorders Treatment Market Hits USD 101.64 Billion in 2032 | Coherent Market Insights

EIN Presswire Georgia, Georgia, Georgia 11 hours ago

<img src=

Retail Pr News

Neuropsychiatric Disorders Treatment Market Hits USD 101.64 Billion in 2032 | Coherent Market Insights

EIN Presswire Georgia, Georgia, Georgia 1 days ago

<img src=

Business Pr News

Global Lung Cancer Therapeutics Market to Reach USD 142.3 Billion as Precision Medicine and Immunotherapy Redefine Oncology Care | Future Market Insights

PR Newswire Europe, Europe, Europe 2 days ago

NEWARK, Del., April 22, 2026 /PRNewswire/ -- According to a latest market analysis by Future Market Insights, the global lung cancer therapeutics market is witnessing strong and sustained growth,...

Retail Pr News

Neuropsychiatric Disorders Treatment Market Hits USD 101.64 Billion in 2032 | Coherent Market Insights

EIN Presswire Georgia, Georgia, Georgia 2 days ago

<img src=

Technology Pr News

Synthetic Small Molecule APIs Market Landscape: Strategic Competition Across Key Regions and Segments

EIN Presswire United Kingdom, United Kingdom, United Kingdom 3 days ago

<a href=#19

Business Pr News

Global Nasal Sprays Market to Reach USD 29.7 Billion by 2036, Driven by Rising Allergy Cases and Non-Oral Drug Demand

PR Newswire Europe, Europe, Europe 3 days ago

NEWARK, Del.,April 21, 2026/PRNewswire/ -- According to the latest market analysis byFuture Market Insights, the globalnasal sprays marketis poised for consistent expansion, supported by rising...

Retail Pr News

Neuropsychiatric Disorders Treatment Market Hits USD 101.64 Billion in 2032 | Coherent Market Insights

EIN Presswire Georgia, Georgia, Georgia 3 days ago

<img src=

Retail Pr News

Neuropsychiatric Disorders Treatment Market Hits USD 101.64 Billion in 2032 | Coherent Market Insights

EIN Presswire Georgia, Georgia, Georgia 4 days ago

<img src=

Retail Pr News

Neuropsychiatric Disorders Treatment Market Hits USD 101.64 Billion in 2032 | Coherent Market Insights

EIN Presswire Georgia, Georgia, Georgia 5 days ago

<img src=

Retail Pr News

Neuropsychiatric Disorders Treatment Market Hits USD 101.64 Billion in 2032 | Coherent Market Insights

EIN Presswire Georgia, Georgia, Georgia 6 days ago

<img src=

Retail Pr News

Neuropsychiatric Disorders Treatment Market Hits USD 101.64 Billion in 2032 | Coherent Market Insights

EIN Presswire Georgia, Georgia, Georgia 7 days ago

<img src=

Emergency Services Pr News

Shingles Treatment Market Growth Overview, Facts & Figures, Segmentation, Future Trends and Historical Analysis By 2033

EIN Presswire United Kingdom, United Kingdom, United Kingdom 8 days ago

<a href=#1024x10

Chemical Industry Pr News

Palisades Therapeutics Secures European Composition‑of‑Matter Patent for TPR1, Now in Ph 2 USDA Citrus Greening Trials

EIN Presswire Japan, Japan, Japan 8 days ago

<a href=#444x

Retail Pr News

Neuropsychiatric Disorders Treatment Market Hits USD 101.64 Billion in 2032 | Coherent Market Insights

EIN Presswire Georgia, Georgia, Georgia 8 days ago

<img src=

Retail Pr News

Long Acting Injectables Market Set to Witness Significant Growth by 2026-2033- Coherent Market Insights

EIN Presswire United Kingdom, United Kingdom, United Kingdom 9 days ago

<img src=

Retail Pr News

Neuropsychiatric Disorders Treatment Market Hits USD 101.64 Billion in 2032 | Coherent Market Insights

EIN Presswire Georgia, Georgia, Georgia 9 days ago

<img src=

Beauty & Hair Care Pr News

Palisades Therapeutics’ PT150 Emerges as First‑in‑Class 'Metabolic Setpoint Modifier' to Lock In GLP‑1 Weight Loss

EIN Presswire Japan, Japan, Japan 9 days ago

<a href=#444x

Chemical Industry Pr News

Palisades Therapeutics Secures European Composition‑of‑Matter Patent for TPR1, Now in Ph 2 USDA Citrus Greening Trials

EIN Presswire New Jersey, New Jersey, United States 9 days ago

<a href=#444x

Chemical Industry Pr News

Palisades Therapeutics Secures European Composition‑of‑Matter Patent for TPR1, Now in Ph 2 USDA Citrus Greening Trials

EIN Presswire New Jersey, New Jersey, United States 10 days ago

<a href=#444x

Retail Pr News

Neuropsychiatric Disorders Treatment Market Hits USD 101.64 Billion in 2032 | Coherent Market Insights

EIN Presswire Georgia, Georgia, Georgia 10 days ago

<img src=

Beauty & Hair Care Pr News

Palisades Therapeutics’ PT150 Emerges as First‑in‑Class 'Metabolic Setpoint Modifier' to Lock In GLP‑1 Weight Loss

EIN Presswire Japan, Japan, Japan 10 days ago

<a href=#444x

Business Pr News

Saphnelo® subcutaneous approved in Canada for the treatment of systemic lupus erythematosus

PR Newswire Canada, Canada, Canada 11 days ago

New self-administration option offers same clinical benefits as Saphnelo IV infusion MISSISSAUGA, ON, April 13, 2026 /CNW/ - Health Canada has granted a Notice of Compliance (NOC) for Saphnelo®...

Business Pr News

Saphnelo® sous-cutané approuvé au Canada pour le traitement du lupus érythémateux disséminé

PR Newswire Canada, Canada, Canada 11 days ago

Une nouvelle option d'auto-administration offre les mêmes bienfaits cliniques que Saphnelo en perfusionIVMISSISSAUGA, ON,le 13 avril 2026/CNW/ - Santé Canada a délivré un avis de conformité (AC)...

Beauty & Hair Care Pr News

Palisades Therapeutics’ PT150 Emerges as First‑in‑Class 'Metabolic Setpoint Modifier' to Lock In GLP‑1 Weight Loss

EIN Presswire Japan, Japan, Japan 11 days ago

<a href=#444x

Retail Pr News

Neuropsychiatric Disorders Treatment Market Hits USD 101.64 Billion in 2032 | Coherent Market Insights

EIN Presswire Georgia, Georgia, Georgia 11 days ago

<img src=